MCAM and ovarian carcinoma: To investigate if the above hypothesis is correct, we compared the expression levels of METCAM/MUC18 in one immortalized normal human ovarian epithelial cell line (IOSE) and five human ovarian cancer cell lines, which were established from primary adenocarcinoma or metastatic ascites [23].